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Article: Prevalence of irritable bowel syndrome: A community based study from Northern India
Makharia GK, Verma AK, Amarchand R, et al
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Irritable bowel syndrome (IBS) is a recurrent disorder char-
acterised by chronic abdominal pain or discomfort (often bloat-
ing), in association with altered generation and interpretation of 
bowel function, which is not accompanied by anatomical anoma-
lies or biochemical abnormalities. Symptoms tend to vary in man-
ifestation and time course, worsen during flares, and affect pa-
tient’s quality of life.
1 A dysregulation of the brain-gut axis that 
interacts with visceral hypersensitivity and associated with observ-
ed digestive motor disturbances and micro-inflammation of the 
gut, with possibly an imbalance of the intestinal bio-flora. These 
are factors that may be responsible for the symptoms generation. 
Psychosocial stressors may then interact with biological factors 
and are modulated by cultural beliefs and practices resulting in 
variations on observed symptoms constellation and health seeking 
behaviours, a biopsychosocial disorder.
A better outcome is achievable if a positive diagnosis of IBS is 
made, based on clinical symptoms (in the absence of alarm signs) 
alone, rather than making a diagnosis by exclusion. Several diag-
nostic criteria exist and each new criterion refers to the insuffi-
ciencies of the previous ones. The most commonly accepted diag-
nostic criteria include the original Manning criteria and the sub-
sequent series of “Rome foundation” defined criteria. A formal 
definition according to the Rome III criteria is recurrent abdomi-
nal pain or discomfort for at least 3 days per month during the 
previous 3 months associated with two or more of the following 
with onset at least 6 months before diagnosis: (1) symptoms im-
provement with defecation, (2) onset associated with a change in 
the frequency of stools and (3) onset associated with a change in 
form or appearance of stools.
1-4
The prevalence of IBS varies across the world, ranging from 
as high as 10%-20% in the West,
5,6 to as low as 4.2% in India.
7 
There is a perception that IBS is less of a problem in Asia and its 
epidemiology to be different. In addition, the prevalence rates of 
IBS itself vary in Asia with higher rates being documented from 
more affluent urban communities of Japan, Singapore and Guang-
zhou in China.
8-10 Prevalence rates also differ within the same 
country (Beijing 7.3% and Guangzhou 12%) and within the same 
racial community from different countries.
8,11,12 Such observed 
differences may be due to the different criteria (Manning vs 
Rome II vs Rome III) used to diagnose IBS or due to a different Prevalence of IBS in Northern India
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target population studied. However more recently, Park et al
13 
reported similar prevalence rates using Rome II (8%) and Rome 
III criteria (9%) in a Korean IBS population.
In this study Makharia et al reported a prevalence rate of 4% 
which is in good agreement (4.2%) with a previous study by Gho-
shal et al.
7 This is interesting as the population involved in both 
studies were quite different. Ghoshal looked at subjects from 
mainly the hospital/clinic setting (recruitment centres from Nor-
thern, Central and Southern India) while the present study was 
solely community based (Northern India). Furthermore Makha-
ria’s group used a questionnaire based on the new Rome III mod-
ule while Ghoshal’s “local criteria” was more clinical and prac-
tical. Yet the resulting prevalence rates from both centers were 
quite similar. The observed prevalence rate is low compared to 
data from other Asian centers and also lower than the Western 
prevalence rates. We would expect lower prevalence rates from a 
rural community in Northern India, as IBS is recognized to be a 
disorder of developed nations and communities.
8-10 However, 
Ghoshal’s hospital based study confirmed that the prevalence rate 
is indeed low in India. 
One possible explanation for the low prevalence rate could be 
from the use of different diagnostic tools or criteria for the de-
tection of a variable condition that is solely symptom based. One 
of the weaknesses of this study is that the used questionnaire was 
not validated for the study population. This might affect the qual-
ity of data acquired. However, a study from Nam et al
14 using va-
lidated Rome III criteria in Korea gave a prevalence rate of 8.2% 
which is still lower than the prevalence rates observed from com-
munities in Europe or America. 
Another unique observation is the much higher incidence of 
diarrhea predominant IBS (1.5%) compared to IBS constipation 
(0.3%). This was also reported from Ghoshal’s study who also 
suggested that in general, Indians tend to pass 1-2 soft stool per 
day. This may be due to the higher fiber intake and faster gut 
transit time. Is it possible that another form of “functional bowel” 
or IBS exist in this sub-continent which is different from the 
West? Western patients tend to be more “neurotic” compared to 
the Asian patients who are more likely to be “post infectious.” 
This difference may also arise from other contributing factors 
such as race, different cultural practices, variation in food intake 
and co-existing lactose intolerance.
The other notable difference reported from this study is the in-
creasing prevalence of IBS with advancing age, with the maxim-
um in the 50-60 age groups. Across Asia, it has been noted that the 
prevalence of IBS is higher in the younger age group.
8,9,11,12,15,16 In 
a rural community where the younger folks need to work hard for 
daily sustenance, symptoms of abdominal discomfort or alteration 
of bowel pattern is often too trivial to be considered as abnormal 
enough to visit the hospital. The time of day in which the study 
was conducted in this native rural community of Northern India 
would also be important. 
The often quoted male preponderance in Asian Indian IBS 
population was not demonstrated in this study. The prevalence of 
IBS was significantly higher in females compared with males. In 
the previous study by Ghoshal et al
7 the subset of complainants in 
the study group showed a distinct predominance of male gender 
(68% vs 32%). The explanation given by the authors is that in a 
male dominant society, the health seeking behaviour of males can 
best account for the disparity in prevalence rates seen in the hos-
pital/clinic setting compared to a rural community setting.
In conclusion, this study by Makharia et al is the first large 
scale IBS study in India using the Rome III criteria. However, 
this study has few limitations. Firstly, the diagnostic tool used, 
the Rome III questionnaire was not validated for this population. 
Secondly, it was also noted that the Glasgow pictorial stool chart 
was not used to determine stool forms. Even if patients can de-
scribe their stool forms adequately, pictorial definition is still the 
best method of evaluation since patient’s perception is often very 
different from the actual stool form. Despite all of these, this 
study has contributed to a better understanding of the epidemiol-
ogy of IBS in India, by providing an alternative view point to the 
more accepted norms. 
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